Yahoo
Canadian Sec - Free Realtime Quote CAD

Telescope Innovations Corp. (TELI.CN)

0.4400 +0.0200 (+4.76%)
As of 9:41:10 AM EDT. Market Open.
Chart Range Bar
Loading chart for TELI.CN
  • Previous Close 0.4200
  • Open 0.4400
  • Bid 0.4300 x --
  • Ask 0.4400 x --
  • Day's Range 0.4400 - 0.4400
  • 52 Week Range 0.3000 - 1.1000
  • Volume 515
  • Avg. Volume 115,467
  • Market Cap (intraday) 35.554M
  • Beta (5Y Monthly) 1.33
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0600
  • Earnings Date (est.) --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Telescope Innovations Corp., a chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada. It offers DIRECTINJECT-LCTM, a hardware and software ecosystem that enables direct sampling and analysis of chemical reactions. It also provides intellectual property and contract research services. It serves pharmaceutical, critical minerals, and chemical industries. Telescope Innovations Corp. has a research collaboration with Pfizer Inc; and Standard Lithium Ltd. to develop a method for producing high-purity lithium sulfide. Telescope Innovations Corp. has a development and collaboration agreement with AGI Group's Synthesis, Digitization, and Automation program to develop the next generation of automation- and AI-ready chemical reactor technology. Telescope Innovations Corp. is based in Vancouver, Canada.

telescopeinnovations.com

--

Full Time Employees

August 31

Fiscal Year Ends

Healthcare

Sector

Biotechnology

Industry

Performance Overview

Trailing total returns as of 8/19/2026, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

TELI.CN
33.33%
S&P/TSX Composite index (^GSPTSE)
15.17%

1-Year Return

TELI.CN
15.79%
S&P/TSX Composite index (^GSPTSE)
31.90%

3-Year Return

TELI.CN
76.00%
S&P/TSX Composite index (^GSPTSE)
85.18%

5-Year Return

TELI.CN
37.50%
S&P/TSX Composite index (^GSPTSE)
81.54%

Statistics

View More

Valuation Measures

Annual
As of 8/17/2026
  • Market Cap

    33.94M

  • Enterprise Value

    35.32M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    4.21

  • Price/Book (mrq)

    9.89

  • Enterprise Value/Revenue

    4.78

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -56.03%

  • Return on Assets (ttm)

    -36.56%

  • Return on Equity (ttm)

    -229.35%

  • Revenue (ttm)

    7.3M

  • Net Income Avi to Common (ttm)

    -4.09M

  • Diluted EPS (ttm)

    -0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.33M

  • Total Debt/Equity (mrq)

    80.05%

  • Levered Free Cash Flow (ttm)

    -5.41M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: